Dr. Brent Sharpe

Dr. Brent Sharpe
Dr. Sharpe received his bachelor’s degree from the University of North Carolina at Charlotte and his Medical Degree from East Carolina University School of Medicine. He completed his residency in Urology at Emory University in 2005 after a surgical internship at Texas Tech Health Science Center. He is board certified by the American Board of Urology. Dr. Sharpe treats all urological conditions but has a special interest in minimally invasive surgery for a wide range of urological conditions such as prostate enlargement (BPH), urological cancers, erectile dysfunction, and vaginal prolapse. He has completed approximately 700 minimally invasive surgeries, making him one of Georgia’s most experienced and extensive minimally invasive urological surgeon. Additionally, he has special expertise in Prosthetic Urology which allows men to have a complete restoration of normal function after prostate cancer treatment. Currently, Dr. Sharpe is the area’s only urologist offering robotic partial nephrectomy, robotic pelvic prolapse surgery, and is Georgia’s first and only surgeon to offer Outpatient Robotic Prostatectomy for prostate cancer. He utilizes specific genetic testing to tailor his prostate cancer treatment plans. Dr. Sharpe is also one of the first surgeons to use biological grafts to enhance the recovery of potency in prostate cancer patients. He was also instrumental in expanding the minimally invasive treatment options in North Carolina, where he practiced prior to coming to northeast Georgia in 2013. Dr. Sharpe and his wife, Victoria, have two sons who love to travel and enjoy the great outdoors.

Languages Spoken:

English

Medical School:

East Carolina University School of Medicine

Residency:

Emory University

Undergraduate:

University of North Carolina at Charlotte

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only